Alogliptin Induced Stomatitis: An Adverse Drug Event Case Report.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pharmacy practice"
DOI: 10.1177/08971900221108721
Abstract: Background: Dipeptidyl peptidase (DPP)-4 inhibitors are commonly used agents to treat type 2 diabetes mellitus (T2DM). Although generally well tolerated, stomatitis has been previously reported as an adverse event with sitagliptin and linagliptin. Stomatitis with… read more here.
Keywords: alogliptin; event; stomatitis; report ... See more keywords